The ZGJTJY treatment mentioned above was found to reduce IL-1β and TNF-α levels in the hippocampus in the rat model of diabetes complicated by depression induced by high-fat emulsion, injection of STZ via coccygeal vein, and chronic stress (Yang et al., 2018). This evidence concerns the gene TNF and depressive symptom measurement.